Visudyne (verteporfin): Information on the continuing supply restriction until end Q1/2022

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Visudyne
Active substance
verteporfin
Therapeutic area (MeSH)
  • Myopia, Degenerative
  • Macular Degeneration
DHPC type
Medicine shortage
Human ATC code
S01LA01
Dissemination date
05/11/2021

How useful was this page?

Add your rating